(Chest. 1999;115:68-74.)
© 1999
American College of Chest Physicians
Lung Volumes in 4,774 Patients With Obstructive Lung Disease*
Brian J. Dykstra, MD;
Paul D. Scanlon, MD, FCCP;
Monica M. Kester, MS;
Ken C. Beck, PhD and
Paul L. Enright, MD
*
From the Rehoboth McKinley Clinic (Dr. Dykstra), Gallup, NM; the Mayo
Clinic (Drs. Scanlon and Beck), Rochester, NY; and the University of Arizona
(Ms. Kester and Dr. Enright), Tuscon, AZ.
 |
Abstract
|
|---|
Study objectives: To determine the correlates of static
lung volumes in patients with airways obstruction, and to determine if
static lung volumes differ between asthma and COPD.
Patients
and methods: We examined the data from all of the adult patients
(mean age of 69) who were referred to a pulmonary function laboratory
from January 1990 through July 1994 with an FEV1/FVC ratio
of < 0.70 and tested using a body plethysmograph. Correlates were
determined using regression analysis.
Measurements and
results: Of the 4,774 patients observed with evidence of
airways obstruction, 61% were men. Self-reported diagnoses included
asthma, 19%; emphysema or COPD, 23%; chronic bronchitis, 1.5%; and
1-antiprotease deficiency, 0.6%. Fifty-six percent of
the patients did not report a respiratory disease. The degree of
hyperinflation, as determined by the residual volume (RV)/total lung
capacity (TLC) ratio, or the RV % predicted (but not the TLC %
predicted), was strongly associated with the degree of airways
obstruction (the FEV1 % predicted). Patients with moderate
to severe airways obstruction and high RV and TLC levels were more
likely to have COPD than asthma. Of the 1,872 patients with a reduced
vital capacity determined by spirometry testing, 87% had
hyperinflation as defined by the RV/TLC, and 9.5% had a low TLC
(with less severe airways obstruction).
Conclusion: In patients found to have airways obstruction
by spirometry, the additional measurement of static lung volumes added
little to the clinical interpretation.
Key Words: asthma COPD hyperinflation lung volumes
 |
Introduction
|
|---|
Static
lung volume tests are often routinely ordered along with spirometry for
patients with various chronic obstructive airway diseases. Two common
reasons for ordering the lung volumes are (1) to determine the presence
or degree of lung hyperinflation, and (2) to look for a superimposed
restrictive lung disorder. Static lung volumes include the total lung
capacity (TLC), the residual volume (RV), and the functional residual
capacity (FRC). The definition of airways obstruction has been
standardized as an abnormally low FEV1/FVC ratio
and a low FEV1 % predicted.1
However, the definition of the term "lung hyperinflation" is
currently imprecise and is variously based on posteroanterior and
lateral chest radiograph patterns, the FRC % predicted, the
RV/TLC ratio, the RV % predicted, or the TLC % predicted.
Thousands of static lung volume tests are performed in pulmonary
function laboratories each year in the United States, with estimated
costs in the range of $75 to $200 per test. The American
Thoracic Society (ATS), the National Heart, Lung, and Blood Institute,
and the European Respiratory Society formed a working group in 1992 to
recommend standards for the measurement and interpretation of static
lung volumes for pediatric and adult patients.2
The
working group noted that there was a paucity of reported data regarding
the correlates of static lung volumes in patients with obstructive lung
diseases, and that the diagnostic or predictive value of static lung
volumes in these common disorders was poorly described.
The goal of this study was to determine the spirometric,
anthropometric, and diagnostic correlates of static lung volumes in
adult patients with airways obstruction noted during spirometry
testing. Our working hypothesis was that the association of
hyperinflation with airway obstruction would differ between asthma,
chronic bronchitis, and emphysema.
 |
Materials and Methods
|
|---|
The study population was comprised of adult outpatients of
> 30 years old who were referred to the Mayo Clinic outpatient
pulmonary function (PF) laboratory in Rochester, MN between January
1990 and July 1994, and who had completed measurements of spirometry
and static lung volumes. All of the patients with a prebronchodilator
FEV1/FVC of > 0.70 were excluded from the
study. The FEV1, the FVC, and the slow vital
capacity (VC) were measured according to ATS
recommendations3
using a model 1070 spirometer (Medical
Graphics; St. Paul, MN) that utilizes a heated Fleisch #3
pneumotachometer. The static lung volumes were measured using a model
1085 pressure-type body plethysmograph (Medical Graphics) according to
standardized methods,4
using slow (1 to 1.5 Hz) panting
maneuvers following the closure of the mouth shutter. The TLC was
determined by measuring the thoracic gas volume (TGV) and adding the
inspiratory capacity performed immediately following the TGV
determination. The RV was calculated by subtracting from the TLC the
largest VC value obtained during any one of the baseline
(prebronchodilator) tests. The FRC (the box TGV) is not reported here
because it is less reproducible than other static lung volumes, and
varies with body position, noseclips, mouthpiece, anxiety, and other
factors. Accuracy checks for body plethysmograph mouth flow, mouth
pressure, and box pressure were performed daily. Spirometry and static
lung volume predicted values were taken from the study of Miller and
coworkers,5
,6
with the fifth percentile used to define the
lower limit of the normal range for the VC and the TLC.
With the patients in their stocking feet, height and weight
measurements were taken. A short respiratory questionnaire included the
question, "Has your doctor ever said you have a lung disease, or any
condition that affects your ability to breathe? If YES, please name the
disease(s)." This questionnaire was administered by the technician
prior to PF tests. Up to three respiratory-related diagnoses were
reported by each patient; the responses were coded and entered into a
data file. The numeric results of all the tests, and the flow-volume
graphs, were stored in an archival database after a quality review.
We also wanted to compare the static lung volumes found in nonsmoking
patients with asthma to the volumes found in former and current smokers
with COPD. Therefore, from the 4,774 patients, we derived two subsets:
"asthma only" and "COPD only." We first eliminated patients who
had reported a pulmonary diagnosis other than asthma, COPD, emphysema,
chronic bronchitis, or bronchitis. We also eliminated patients who had
reported any type of lung surgery, lung biopsy, or lung resection. The
"asthma only" group had to report asthma as a diagnosis (but could
also have reported bronchitis), and current smokers or former smokers
were excluded from the asthma group. The COPD only group had to have
reported either COPD, emphysema, or chronic bronchitis as a diagnosis
(but could have additionally listed bronchitis) and must have reported
a > 30-pack-year smoking history.
Data transformations, descriptive statistics, linear regression models,
and graphs were performed using SPSS for Windows, version 5, with the
RV/TLC x 100%, the RV % predicted, or the TLC % predicted
as continuous dependent variables.7
We used the
FEV1 % predicted as an index of the severity of
airways obstruction as recommended by the ATS.1
We
determined the ranges of the significant differences in the linear
regression lines of the associations of hyperinflation with the degree
of airways obstruction between the asthma and COPD groups by using the
methods of Zerbe and coworkers.8
 |
Results
|
|---|
There were 4,774 adult patients who met the entry criteria of an
FEV1/FVC of < 0.70; 61% were men, and the mean
age was 69 (see Fig 1
for the age distribution). At the time of testing, 908 patients (19%)
reported a diagnosis of asthma, 1,099 patients (23%) reported a
diagnosis of emphysema or COPD, 70 patients (1.5%) reported chronic
bronchitis, 31 patients (0.6%) reported an
1-antiprotease (AAP) deficiency, and
56% did not report having a respiratory disease. More than one
respiratory diagnosis was reported by 11.2% of the patients, and 78%
of the patients reported being current or former smokers (see Table 1
for the mean PF values).
Hyperinflation
In the overall group of 4,774 patients, the degree of
hyperinflation was significantly associated with the degree of airways
obstruction, as indicated by the FEV1 %
predicted: the bivariate correlation coefficients for the RV/TLC
%, the RV % predicted, and the TLC % predicted with the
FEV1 % predicted were all highly significant,
respectively: 0.76, 0.66, and 0.33 (p < 0.0001). All three
indices of hyperinflation were also significantly associated with a
self-reported diagnoses of asthma and emphysema, and with age, gender,
height, weight, and smoking status (patients who never smoked vs former
or current smokers).
All of the variables mentioned above were then offered as predictor
variables to each of the three separate linear regression models, with
dependent variables of the RV/TLC %, the RV % predicted, and
the TLC % predicted. Entry was stepwise, with a p< 0.01 (in) and a
p> 0.05 (out). Most of the variability of the RV/TLC was
explained by the degree of airways obstruction (the
FEV1 % predicted), height, age, and gender (see
Table 2
). Chronic bronchitis, emphysema, and smoking status were not
independent predictors of the degree of hyperinflation as measured by
the RV/TLC %, and the mean RV/TLC % was only 0.6%
higher for those reporting asthma when compared to the other patients.
Similar to the RV/TLC %, the independent correlates of
hyperinflation as measured by the RV % predicted also included the
degree of airways obstruction, and the patient's height, age, and
gender (see Table 3
). However, the reported type of obstructive lung disease also made a
difference: after correcting for the above variables, the mean RV %
predicted was 35% higher for patients with an AAP deficiency, 13%
higher for those reporting emphysema, and 8% higher for those
reporting asthma when compared to patients not reporting these
diagnoses. Current smokers also had a mean RV % predicted that was 5%
higher than what was found in patients who had never smoked or had quit
smoking.
Ninety percent of the TLC variability resulted from factors not
measured by this study. The independent correlates of the TLC %
predicted included gender, age, and height, but not the degree of
airways obstruction (see Table 4
). The effects of asthma, emphysema, and the AAP deficiency on the TLC
were less than their effect on the RV. Current smoking was also
independently associated with a higher TLC. Obesity was independently
associated with both a lower RV and a lower TLC. Patients whose body
weight was 20 kg (44 lb) heavier than average had a 6% lower RV and a
4% lower TLC.
Asthma vs COPD
Table 5
shows the mean anthropometric and PF values for the two patient
subgroups of (1) never-smokers who reported asthma only (n = 268),
and (2) smokers who reported COPD only (n = 668). The mean age,
height, and weights were similar, but there were more men with COPD
only. The COPD patients had more severe airways obstruction and more
hyperinflation when compared to those reporting asthma only.
The strong association of the degree of RV/TLC hyperinflation
with the degree of airways obstruction was virtually identical in both
asthma and COPD patients (see Fig 2
). On the other hand, for patients with moderate to severe airways
obstruction (an FEV1 of < 53% of predicted),
the mean RV was higher in patients with COPD only (an RV of usually
> 200% of predicted and up to 350% of predicted) when compared to
patients with asthma only (see Fig
3
).

View larger version (26K):
[in this window]
[in a new window]
[Download PPT slide]
|
Figure 2. The association of RV/TLC ratio
(RV/TLC %) with the severity of airways obstruction
(FEV1 % predicted) in patients with asthma only (open
circles) and COPD only (solid squares).
|
|
Hyperinflation of the TLC was not associated with the degree of airways
obstruction in the entire group of 4,774 patients or in the subgroup
with asthma only (see Fig 4
). However, patients with moderate to severe airways obstruction
resulting from COPD were more likely than patients with mild airways
obstruction to have a high TLC (from 120 to 180% of predicted).

View larger version (28K):
[in this window]
[in a new window]
[Download PPT slide]
|
Figure 4. The association of the % of predicted total lung
capacity (TLC % predicted) with the severity of airways obstruction
(FEV1 % predicted) in patients with asthma only (open
circles) and COPD only (solid squares). The two regression lines are
significantly different below the 59% of predicted FEV1.
|
|
Superimposed Restriction
Of the total of 4,774 patients, 1,872 patients (39.2%) had a
reduced VC. Of these patients, 1,634 patients (87.3%) had a high
RV/TLC (above the normal range), and only 177 patients (9.5%)
had a low TLC (below the lower limit of the normal range). The mean
FEV1/FVC was significantly higher for patients
with a low TLC when compared to the other patients, respectively: 62 vs
51% (p < 0.001). Patients with a low TLC were also less likely than
the other patients to have a severe airways obstruction (an
FEV1 of < 40% of predicted), respectively:
36 vs 52% (p < 0.001).
 |
Discussion
|
|---|
In this large retrospective study of patients referred to a single
PF laboratory, we have confirmed that hyperinflation of lung volumes is
associated with the degree of airway obstruction. However, the strength
of this association, as well as other clinical correlates, vary
considerably according to whether "hyperinflation" is defined as a
high RV/TLC, a high RV, or a high TLC. The RV or the
RV/TLC are much more sensitive than the TLC to the degree of
airways obstruction (see
Figs 2
,3
,4
). As airways obstruction moves from
borderline (90% of predicted FEV1) to moderate
(50% of predicted FEV1), the mean RV increases
from 100 to 140% of predicted (see Fig 3
) while the TLC remains
relatively constant (see Fig 4
).

View larger version (24K):
[in this window]
[in a new window]
[Download PPT slide]
|
Figure 3. The association of increase in the log RV %
predicted with airways obstruction (FEV1 % predicted) in
patients with asthma only (open circles) and COPD only (solid squares).
The two regression lines are significantly different below the 53% of
predicted FEV1.
|
|
As previously reported in healthy individuals,5
,9
the RV was larger in men, taller patients, and younger patients with
airways obstruction. In addition, patients who weighed more had a lower
RV. After correcting for gender, height, and age, the RV was strongly
correlated with the FEV1 % predicted. On
average, the RV was 14% higher for each 10% decrease in the
FEV1. Patients (n = 31) reporting an AAP
deficiency had much higher RV levels (+ 35%) than the other
patients. Patients reporting emphysema had somewhat higher RVs
(+ 13%) when compared to patients reporting asthma (+ 8%), after
correcting for the degree of airways obstruction. Chronic bronchitis
was not independently associated with static lung volumes
(RV/TLC, RV, or TLC).
Our results confirm a review10
of the indications for the
measurement of static lung volumes stating that "in patients with
COPD, RV and FRC are elevated in proportion to the degree of airflow
obstruction; TLC, on the other hand, may be affected variably by the
different obstructive diseases: elevated in emphysema but often normal
in chronic bronchitis and asthma, for the same degree of flow
obstruction."
A review11
of the differential diagnosis of emphysema,
chronic bronchitis, and asthma stated that "although elevations of
static lung volumes are associated almost exclusively with these
obstructive lung diseases, measurement of static lung volumes have not
proven useful for separating these three classic diagnostic
categories." We generally agree with this statement because there is
a large overlap in the degree of hyperinflation seen in these
obstructive diseases in our patients; however, in patients with
moderate to severe airways obstruction, patients with COPD tend to have
higher levels of RV and TLC when compared to patients with asthma.
Decades ago, investigators demonstrated that static lung volumes in
cigarette smokers were associated with the degree of anatomic
emphysema, but they did not attempt to correct for the degree of
airways obstruction. Asthma has also been associated with increases in
lung volumes during acute bronchospasm and during asymptomatic
periods.12
,13
Some of the increase in TLC noted during
induced bronchospasm was due to an artifact of measurement, because
mouth pressure does not reflect alveolar pressure well during panting
maneuvers in patients with severe airways
obstruction.14
,15
More recent measurements of the TLC
using chest radiograph planimetry showed that the TLC does
increase slightly during bronchospasm.16
However, our
results do not support an association of TLC with the degree of airways
obstruction in adult patients with asthma.
A population study of 2,680 subjects in Italy found that the RV was
inversely related to weight in healthy adult women.9
Our
results confirm this finding in both men and women with airways
obstruction (see Table 3
). Perhaps reference equations for
RV17
should include a correction for body weight. We also
found that current smokers (when compared with ex-smokers) had higher
values of RV and TLC, after correcting for other factors (see Tables 3,
4), although the Italian study9
found this
association only in men.
A limitation of the present study is the use of self-reporting when
classifying lung disease patients. Some patients may not remember
correctly the diagnosis given to them by their physician. Some patients
undoubtedly had lung disease but had not been told so by their
physician. Some patients were sent to the PF lab because of a history
suggesting lung disease, and the results may have then prompted their
physician to apply a lung disease diagnosis (which we did not obtain).
The predicted values of Miller and coworkers5
,6
were used because both spirometry and static lung volume reference
values were available from the same population sample. We did not use
single- or multiple-breath helium dilution techniques (or nitrogen
washout) to measure static lung volumes, because these methods are
known to seriously underestimate lung volumes in patients with moderate
to severe airways obstruction when compared with body
plethysmography.18
Errors in the measurement of lung
volumes using body plethysmography (without using an esophageal balloon
to estimate alveolar pressure changes) are also known to occur in
patients with severe airways obstruction14
, but these are
very small when compared with measurements of the TLC from chest
radiographs, especially if rapid panting during airway occlusion is
avoided,15
,18
as in our study.
In summary, the measurement of static lung volumes in adult patients
with airways obstruction did not distinguish well the two major types
of airways obstruction (asthma and COPD). In patients with airways
obstruction and a low VC on spirometry testing, only 9.5% were found
to have a superimposed restrictive process (a low TLC).
 |
Footnotes
|
|---|
Correspondence to: Paul Enright, MD, Respiratory Sciences
Center, 1501 N Campbell Blvd, Tucson, AZ 85724; e-mail:
lungguy@aol.com
Abbreviations: AAP =
1-antiprotease;
ATS = American Thoracic Society; FRC = functional residual
capacity; PF = pulmonary function; RV = residual volume;
TGV = thoracic gas volume; TLC = total lung capacity; VC = vital
capacity
Received for publication February 24, 1998.
Accepted for publication June 9, 1998.
 |
References
|
|---|
-
. American Thoracic Society. (1991) Lung function testing: selection of reference values and interpretative strategies. Am Rev Respir Dis 144,1202-1218[ISI][Medline]
-
Clausen, JL, Coates, AL, Quanjer, PH (1997) Measurement of lung volumes in humans: review and recommendations from an ATS/ERS workshop. Eur Respir J 10,1205-1206[CrossRef][ISI][Medline]
-
. American Thoracic Society. (1987) Standardization of spirometry: 1987 update. Am Rev Respir Dis 136,1285-1298[ISI][Medline]
-
Coates, AL, Peslin, R, Rodenstein, D, et al (1997) Measurement of lung volumes by plethysmography. Eur Respir J 10,1415-1427[CrossRef][ISI][Medline]
-
Miller, A, Thornton, J, Warshaw, R, et al (1983) Single breath diffusing capacity in a representative sample of the population of Michigan, a large industrial state. Am Rev Respir Dis 127,270-277[ISI][Medline]
-
Miller, A, Thornton, JC, Warshaw, R, et al (1986) Mean and instantaneous expiratory flows, FVC and FEV1: prediction equations from a probability sample of Michigan, a large industrial state. Bull Eur Physiopathol Respir 22,589-597[ISI][Medline]
-
Norusis MJ. SPSS for Windows, Base System User's Guide, Release 6.0. Chicago, IL: SPSS, 1993
-
Zerbe, GO, Archer, PG, Banchero, N, et al (1982) On comparing regression lines with unequal slopes. Am J Physiol 242,R178-R180[Medline]
-
Paoletti, P, Viegi, G, Carrozzi, L, et al (1992) Residual volume in a general population: effects of body size, age, cigarette smoking, and respiratory symptoms. Chest 102,1209-1215[Abstract/Free Full Text]
-
Ries, AL (1989) Measurement of lung volumes. Clin Chest Med 10,177-186[ISI][Medline]
-
Clausen, JL (1990) The diagnosis of emphysema, chronic bronchitis, and asthma. Clin Chest Med 11,405-416[Medline]
-
Woolcock, AJ, Read, J (1966) Lung volumes in exacerbations of asthma. Am J Med 41,259-273[CrossRef][ISI][Medline]
-
Greenough, A, Everett, L, Pool, J, et al (1991) A 2-year longitudinal study of lung hyperinflation in young asthmatics. Respir Med 85,379-382[Medline]
-
Rodenstein, DO, Stanescu, DC, Francis, C (1982) Demonstration of failure of body plethysmography in airway obstruction. J Appl Physiol 52,949-954[Abstract/Free Full Text]
-
Shore, SA, Huk, O, Mannix, S, et al (1983) Effect of panting frequency on the plethysmographic determination of thoracic gas volume in chronic obstructive pulmonary disease. Am Rev Respir Dis 128,54-59[ISI][Medline]
-
Blackie, SP, al-Majed, S, Staples, CA, et al (1990) Changes in total lung capacity during acute spontaneous asthma. Am Rev Respir Dis 142,79-83[ISI][Medline]
-
Stocks, J, Quanjer, PH (1995) Reference values for residual volume, functional residual capacity, and total lung capacity: ATS workshop on lung volume measurementsofficial statement of the European Respiratory Society. Eur Resp J 8,492-506[CrossRef][ISI][Medline]
-
Andersson, LG, Ringqvist, I, Walker, A (1988) Total lung capacity measured by body plethysmography and by the helium dilution method: a comparative study in different patient groups. Clin Physiol 8,113-119[Medline]
This article has been cited by other articles:

|
 |

|
 |
 
D. E. O'Donnell, F. Sciurba, B. Celli, D. A. Mahler, K. A. Webb, C. J. Kalberg, and K. Knobil
Effect of Fluticasone Propionate/Salmeterol on Lung Hyperinflation and Exercise Endurance in COPD.
Chest,
September 1, 2006;
130(3):
647 - 656.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
J. E. Hansen, X.-G. Sun, and K. Wasserman
Discriminating measures and normal values for expiratory obstruction.
Chest,
February 1, 2006;
129(2):
369 - 377.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
R. Pellegrino, G. Viegi, V. Brusasco, R. O. Crapo, F. Burgos, R. Casaburi, A. Coates, C. P. M. van der Grinten, P. Gustafsson, J. Hankinson, et al.
Interpretative strategies for lung function tests
Eur. Respir. J.,
November 1, 2005;
26(5):
948 - 968.
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
M. F. Newton, D. E. O'Donnell, and L. Forkert
Response of Lung Volumes to Inhaled Salbutamol in a Large Population of Patients With Severe Hyperinflation*
Chest,
April 1, 2002;
121(4):
1042 - 1050.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
K. O. Hadeli, E. M. Siegel, D. L. Sherrill, K. C. Beck, and P. L. Enright
Predictors of Oxygen Desaturation During Submaximal Exercise in 8,000 Patients
Chest,
July 1, 2001;
120(1):
88 - 92.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
C. CASSINO, K. I. BERGER, R. M. GOLDRING, R. G. NORMAN, S. KAMMERMAN, C. CIOTOLI, and J. REIBMAN
Duration of Asthma and Physiologic Outcomes in Elderly Nonsmokers
Am. J. Respir. Crit. Care Med.,
October 1, 2000;
162(4):
1423 - 1428.
[Abstract]
[Full Text]
[PDF]
|
 |
|